Urodie Brand names, Urodie Analogs
Urodie Brand Names Mixture
Urodie fda sheet
Urodie msds (material safety sheet)
Urodie Synthesis Reference
M. Winn et al., U.S. Pat. 4,026,894 (1977)
Urodie Molecular Weight
Urodie Melting Point
Urodie H2O Solubility
Urodie Dosage Forms
For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.
Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.
Essentially completely absorbed in man (90% bioavailability).
Urodie side effects and Toxicity
LD50=259.3mg/kg (i.v. in mice)
Urodie Patient Information
Urodie Organisms Affected
Humans and other mammals